The signaling pathway of Toll-like Receptor 4 (TLR4) plays a central role in Dox-induced cardiac inflammation (Sumneang et al., 2023), which may be consistent with the mechanism of arrhythmia induced by ibrutinib. Here, TLR4 is linked to cardiac arrhythmia.